Tenet Healthcare Future Growth
Future criteria checks 0/6
Tenet Healthcare's earnings are forecast to decline at 35.9% per annum while its annual revenue is expected to grow at 2.7% per year. EPS is expected to decline by 39% per annum. Return on equity is forecast to be 14.5% in 3 years.
Key information
-35.9%
Earnings growth rate
-39.0%
EPS growth rate
Healthcare earnings growth | 17.1% |
Revenue growth rate | 2.7% |
Future return on equity | 14.5% |
Analyst coverage | Good |
Last updated | 12 Jun 2024 |
Recent future growth updates
Recent updates
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
May 21Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit
Apr 30Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Mar 18Tenet Healthcare: Shrinking To Grow
Feb 04Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks
Dec 18We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt
Nov 15Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt
Oct 13Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?
Aug 02Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now
Jul 28Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?
Apr 13USPI and Providence extend hands to aid ambulatory surgical services
Feb 09Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Jan 31Tenet Healthcare: Compressed Multiples Appear Justified
Jan 27Tenet Health gains on on report David Einhorn's Greenlight has stake
Jan 17An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued
Jan 13Tenet Healthcare: Earnings Headwinds With Mixed Technicals
Nov 11Tenet Healthcare Q3 2022 Earnings Preview
Oct 19Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Oct 09Tenet Healthcare: Mixed Debate, Rate Neutral On Valuation
Aug 25Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22,243 | 964 | N/A | 2,513 | 11 |
12/31/2025 | 21,220 | 891 | 1,327 | 2,333 | 17 |
12/31/2024 | 20,397 | 2,729 | 3,463 | 1,854 | 17 |
3/31/2024 | 20,892 | 2,619 | 1,755 | 2,511 | N/A |
12/31/2023 | 20,548 | 611 | 1,623 | 2,374 | N/A |
9/30/2023 | 20,162 | 469 | 1,138 | 1,971 | N/A |
6/30/2023 | 19,897 | 499 | 961 | 1,783 | N/A |
3/31/2023 | 19,453 | 414 | 462 | 1,304 | N/A |
12/31/2022 | 19,174 | 410 | 321 | 1,083 | N/A |
9/30/2022 | 19,040 | 558 | 243 | 1,019 | N/A |
6/30/2022 | 19,133 | 875 | 414 | 1,136 | N/A |
3/31/2022 | 19,449 | 957 | 570 | 1,262 | N/A |
12/31/2021 | 19,485 | 915 | 910 | 1,568 | N/A |
9/30/2021 | 19,544 | 1,079 | 1,137 | 1,657 | N/A |
6/30/2021 | 19,207 | 434 | 1,323 | 1,818 | N/A |
3/31/2021 | 17,901 | 402 | 3,333 | 3,812 | N/A |
12/31/2020 | 17,640 | 399 | 2,867 | 3,407 | N/A |
9/30/2020 | 17,531 | -18 | 2,929 | 3,481 | N/A |
6/30/2020 | 17,542 | -48 | 2,685 | 3,307 | N/A |
3/31/2020 | 18,454 | -112 | 692 | 1,352 | N/A |
12/31/2019 | 18,479 | -226 | 563 | 1,233 | N/A |
9/30/2019 | 18,292 | -228 | 258 | 963 | N/A |
6/30/2019 | 18,213 | -10 | 197 | 882 | N/A |
3/31/2019 | 18,159 | -10 | 280 | 946 | N/A |
12/31/2018 | 18,313 | 101 | 432 | 1,049 | N/A |
9/30/2018 | 18,672 | -117 | 671 | 1,290 | N/A |
6/30/2018 | 18,769 | -474 | 633 | 1,260 | N/A |
3/31/2018 | 19,065 | -554 | 475 | 1,127 | N/A |
12/31/2017 | 19,179 | -704 | N/A | 1,200 | N/A |
9/30/2017 | 19,061 | -553 | N/A | 416 | N/A |
6/30/2017 | 19,324 | -196 | N/A | 377 | N/A |
3/31/2017 | 19,390 | -184 | N/A | 597 | N/A |
12/31/2016 | 19,621 | -187 | N/A | 558 | N/A |
9/30/2016 | 19,787 | -208 | N/A | 1,042 | N/A |
6/30/2016 | 19,630 | -227 | N/A | 1,255 | N/A |
3/31/2016 | 19,254 | -243 | N/A | 1,230 | N/A |
12/31/2015 | 18,634 | -142 | N/A | 1,026 | N/A |
9/30/2015 | 18,073 | 19 | N/A | 1,054 | N/A |
6/30/2015 | 17,556 | 57 | N/A | 793 | N/A |
3/31/2015 | 17,101 | 107 | N/A | 649 | N/A |
12/31/2014 | 16,603 | 34 | N/A | 687 | N/A |
9/30/2014 | 16,023 | -44 | N/A | 723 | N/A |
6/30/2014 | 14,256 | -21 | N/A | 708 | N/A |
3/31/2014 | 12,641 | -64 | N/A | 602 | N/A |
12/31/2013 | 11,087 | -123 | N/A | 589 | N/A |
9/30/2013 | 9,548 | -50 | N/A | 590 | N/A |
6/30/2013 | 9,361 | -53 | N/A | 520 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: THC's earnings are forecast to decline over the next 3 years (-35.9% per year).
Earnings vs Market: THC's earnings are forecast to decline over the next 3 years (-35.9% per year).
High Growth Earnings: THC's earnings are forecast to decline over the next 3 years.
Revenue vs Market: THC's revenue (2.7% per year) is forecast to grow slower than the US market (8.4% per year).
High Growth Revenue: THC's revenue (2.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: THC's Return on Equity is forecast to be low in 3 years time (14.5%).